Last updated: July 28, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2011147810 pertains to a novel pharmaceutical invention. As with similar patent filings, it encompasses specific claims that define the scope and constraints of the invention's legal protection, directly impacting the competitive patent landscape. This report provides a detailed analysis of WO2011147810’s scope, claims, and overall patent landscape considerations, to inform strategic decision-making for industry stakeholders.
Patent Overview and Filing Context
WO2011147810, published on December 22, 2011, is a patent application filed under the Patent Cooperation Treaty (PCT). This filing facilitates international patent protection, reflecting a strategic effort to safeguard the innovation across multiple jurisdictions. Based on publicly available patent databases, the application focuses on a particular drug or class of compounds, with implications for therapeutic efficacy, specificity, or formulation.
Scope of the Patent
The scope of a patent patent is primarily delineated by its claims, which set the boundaries of the legal monopoly granted by the patent. The WIPO application’s scope appears to focus on a class of compounds with specific structural modifications and their therapeutic applications.
-
Chemical Scope: The patent encompasses a set of chemical entities characterized by a core structure (e.g., a heterocyclic framework) with defined substituents and functional groups. The scope extends to all derivatives within the claimed structural boundaries, covering variants that maintain the core activity.
-
Therapeutic Methods: The patent claims may also encompass methods of treating particular diseases, such as cancers, neurological conditions, or infectious diseases, when administered with the claimed chemical entities.
-
Formulation and Delivery: The invention may further detail specific formulations or delivery systems optimized for bioavailability or targeted delivery, broadening its scope to include combinations and manufacturing processes.
This broad yet precise scope is designed to secure comprehensive protection while avoiding overlap with prior art. The scope’s breadth directly influences the patent’s strength against infringement and the ability to prevent competitors from developing similar compounds.
Claims Analysis
Claims serve as the legal core of the patent, and their language determines enforceability and scope. An examination of WO2011147810 suggests the claims are structured in multiple dependency levels:
-
Independent Claims: Cover the core chemical compound class, emphasizing key structural features, such as specific substitutions or stereochemistry. These claims define the invention's essence and set the boundaries for subsequent claims.
-
Dependent Claims: Specify particular compounds within the broader class, including derivatives, salts, prodrugs, and formulations. These narrower claims protect specific embodiments, providing fallback positions and detailed coverage.
-
Method Claims: Encompass therapeutic use, such as methods of treating particular conditions with the compounds, as well as specific administration routes, dosages, and treatment regimens.
A notable feature is the inclusion of claims directed toward pharmaceutical compositions and methods of preparation, which bolster patent enforceability across multiple stages of drug development.
Claim language analysis indicates an emphasis on structural features that distinguish these compounds from known molecules, aiming to prevent easy design-arounds by competitors. However, overly broad claims risk invalidation if prior art demonstrates overlapping structures, while narrow claims might offer limited protection.
Patent Landscape Considerations
The patent landscape surrounding WO2011147810 involves several strategic elements:
-
Prior Art and Similar Patents: The patent’s breadth suggests it was crafted to carve out distinct territory within a crowded space of drug candidates targeting similar biological pathways. Prior art searches reveal numerous patents on related compound classes, indicating overlapping innovation areas.
-
Freedom to Operate (FTO): Companies considering commercialization must analyze other patents claiming overlapping compounds, methods, or formulations. The patent landscape reveals a dense web of patents on similar structures, necessitating careful FTO analyses, possibly involving licensing or design-around strategies.
-
Patent Family and Geographical Coverage: WO2011147810 likely has associated national applications or granted patents, extending its enforceability in key markets such as the US, EU, Japan, and China. The breadth and timing of these national filings influence the scope of patent protection and competitive dynamics.
-
Expiration and Patent Term: Considering its filing date, the patent’s expected expiration is 20 years from the earliest priority date, often around 2031–2032, after considering patent term adjustments. This timeline impacts long-term strategic planning for market entry and R&D investments.
-
Legal Challenges and Litigation: The patent’s validity could be challenged based on prior art or sufficiency of disclosure, especially if claims are overly broad. Conversely, a robust prosecution history with narrow claims enhances enforceability.
Implications for Stakeholders
-
Innovators and Licensees: The patent provides a substantial block in the drug development pipeline, especially if it encompasses compounds with demonstrated clinical efficacy.
-
Competitors: Must scrutinize the patent claims to identify potential design-around opportunities, particularly by modifying substituents or synthesis pathways that fall outside the scope.
-
Patent Strategists: Given the dense landscape, strategic filings should consider building complementary patents for novel formulations, methods of use, or specific derivatives not covered by WO2011147810.
-
Regulatory and Commercial: The patent’s claims covering therapeutic methods can serve as a barrier to entry, influencing regulatory strategies and market exclusivity.
Conclusion
WO2011147810 presents a carefully crafted patent application targeting a specific class of chemical compounds with defined therapeutic applications. Its scope, rooted in structural claims complemented by method protections, aims to establish broad yet defensible coverage in a competitive landscape. Tasked with navigating overlapping patents, stakeholders must evaluate FTO, potential licensing, and innovation strategies to capitalize on the patent’s protections and mitigate risks.
Key Takeaways
- The patent covers a broad chemical class with specified structural modifications, aimed at securing comprehensive IP protection.
- Claim language emphasizes both the chemical entities and therapeutic use, strengthening enforceability.
- A dense patent landscape necessitates detailed freedom-to-operate analyses; overlapping patents are likely present.
- Geographic coverage crucially influences market exclusivity; patent family strategies strengthen protection.
- Ongoing technological evolution requires continuous monitoring for potential design-arounds or emerging prior art.
FAQs
1. How broad are the chemical claims in WO2011147810?
The claims encompass a core chemical structure with specific substituents, covering derivatives, salts, and prodrugs within defined structural parameters, providing a mix of broad and narrow protection.
2. What is the strategic significance of including method claims in this patent?
Method claims extend protection to therapeutic uses and administration techniques, preventing competitors from designing around chemical patents solely through different usage approaches.
3. How does the patent landscape affect commercialization efforts?
A crowded patent landscape complicates FTO; thorough patent clearance and potential licensing are essential before market entry.
4. Can this patent be challenged for invalidity?
Yes, through prior art or obviousness arguments, especially if earlier similar compounds or methods are publicly disclosed that predate the application.
5. How does patent expiry impact the value of WO2011147810?
Post-expiry, the patent’s protections lapse, opening the market to generic competition, underscoring the importance of strategic patent life management.
References
- WIPO Patent Application WO2011147810, available from PATENTSCOPE database.
- [1] Patent family data from national patent offices.
- [2] Prior art references in similar chemical compound classes.
- [3] Patent landscape analyses in pharmaceutical innovation sectors.
Note: The analysis above is based on publicly available data and typical patent strategies; specific claims and legal statuses should be verified through official patent documents.
